Clinical trial Recruiting at 1 site Interventional Ages 30 to 65

Early-Phase Graded Motor Imagery after Massive Rotator Cuff Repair

Official title: The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair

Run by Acibadem University · NCT07481864 · Data updated 2026-11-12

This study tests whether graded motor imagery can help people recover motor control and reduce pain after a large rotator cuff repair.

Quick facts

Study typeInterventional
Ages30 Years to 65 Years
SexAll
Enrollment38 (estimated)
SponsorAcibadem University
Academic / other
Locations1 site (Istanbul, Turkey)
StatusRecruiting
StartedMarch 15, 2026
Main results expectedJune 1, 2026
Study endsSeptember 15, 2026
Registry record updatedJuly 15, 2026
Trial IDNCT07481864 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30–65 who recently underwent arthroscopic repair of an anterior-superior rotator cuff tear involving the supraspinatus and subscapularis tendons.

Probably not a fit

Individuals outside the age range, with more extensive or different tendon involvement, or with conditions that limit participation may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study explores the use of graded motor imagery as an early rehabilitation tool following arthroscopic repair of massive rotator cuff tears. The approach combines laterality recognition, motor imagery, and mirror therapy to target cortical processing and potentially improve pain and shoulder function during the protected postoperative period. Eligible participants are adults aged 30–65 with repaired anterior-superior rotator cuff tears involving the supraspinatus and subscapularis tendons. The study is led by Acibadem University in Istanbul, Turkey, and aims to determine whether GMI is feasible and beneficial in this specific postoperative setting.

Why it matters

Potential benefit: If successful, patients may experience less pain and faster restoration of shoulder function in the early recovery phase.

How similar studies have gone: Previous research in other musculoskeletal conditions suggests graded motor imagery can modulate pain and improve function, but its use in early postoperative shoulder rehab is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 30 and 65 years
* Presence of an arthroscopically repaired anterior-superior rotator cuff tear, involving the supraspinatus and subscapularis tendons

Exclusion Criteria:

* Age younger than 30 years or older than 65 years

  * Presence of severe malignant, hematological, endocrine, metabolic, rheumatologic, or gastrointestinal diseases
  * Diagnosis of glenohumeral osteoarthritis (Kellgren-Lawrence grade III or higher, with radiographic evidence of osteophytes)
  * Current treatment with cytotoxic agents or systemic corticosteroids
  * Alcohol dependence, history of substance abuse, or psychological/emotional disorders that may compromise the validity of informed consent
  * Previous surgery on the ipsilateral shoulder
  * Multiple tendon tears, such as combined tears involving the supraspinatus together with the infraspinatus or subscapularis tendons

Where it's running

  • Acibadem University
    Istanbul, Turkey, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.